de Boisriou, Isaure http://orcid.org/0009-0007-8406-3250
Ellouze, Sami http://orcid.org/0000-0003-2268-7539
Kassasseya, Christian http://orcid.org/0000-0003-2045-4985
Feral-Pierssens, Anne-Laure
Gerlier, Camille http://orcid.org/0000-0003-1991-4083
Chauvin, Anthony http://orcid.org/0000-0001-8819-0061
Beaune, Sebastien http://orcid.org/0000-0001-9299-6703
Dubreucq, Evelyne http://orcid.org/0009-0001-7412-8619
Pereira, Laurent
Chocron, Richard http://orcid.org/0000-0002-5498-8937
Khellaf, Mehdi http://orcid.org/0000-0001-5009-4744
Mariotte, Éric http://orcid.org/0000-0002-3614-0457
Zafrani, Lara http://orcid.org/0000-0002-7805-3116
Peyrony, Olivier http://orcid.org/0000-0001-6831-0054
Article History
Received: 28 July 2023
Accepted: 8 October 2023
First Online: 1 November 2023
Declarations
:
: OP has received honoraria for talks on behalf of BMS and Qiagen, and expertise for Sanofi. EM has received lecture fees from Sanofi and Takeda. LZ reports receiving fees for lectures for MSD and Sanofi and her institution received a research grant from Jazz Pharmaceuticals.
: Not applicable.
: The collection and use of data was approved by the institutional review board (CIC Clermont-Ferrand — IRB no. 5891; Ref: 2007–16).